Showing results (591-600 of 834) with videos related to

Sort By:
Pageof 84
American Journal of Nephrology|March 31, 2026
Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysisAjay K Singh, Stefan D Anker, Bertram Pitt, et al.
Diabetes, Obesity & Metabolism|March 31, 2026
Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular UltrasoundLuis F Ferreira-Divino, Christina G Poulsen, Viktor Rotbain Curovic, et al.
Kidney International|July 27, 2026
New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomesMark André de la Rambelje, Niels Jongs, Peter J Greasley, et al.
Journal of Nutrition Education and Behavior|April 30, 2025
Time-Restricted Eating is a Feasible Dietary Strategy in the Treatment of Complicated Type 2 Diabetes: The RESET2 Pilot StudyAnne-Ditte Termannsen, Annemarie Varming, Gitte S Hansen, et al.
Journal of Hypertension|August 4, 2015
Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetesMichelle J Pena, Joachim Jankowski, Georg Heinze, et al.
Diabetes, Obesity & Metabolism|August 13, 2025
Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetesJonas A Andersen, Tommi Suvitaival, Kajetan Trošt, et al.
Infection|September 10, 2025
Infective endocarditis and relationship with diabetes mellitus - Patient characteristics, microbial etiology and mortalityAndreas Dalsgaard Jensen, Lauge Østergaard, Peter Laursen Graversen, et al.
Diabetes, Obesity & Metabolism|October 22, 2024
The associations between functional vitamin K status and all-cause mortality, cardiovascular disease and end-stage kidney disease in persons with type 1 diabetesCamilla Friis Bryde Nielsen, Sanne Møller Thysen, Freja Bach Kampmann, et al.
Cardiovascular Diabetology|April 27, 2018
Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetesRomain Charmet, Seamus Duffy, Sareh Keshavarzi, et al.
Pageof 84